vs
Side-by-side financial comparison of TOP SHIPS INC. (TOPS) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.
Viridian Therapeutics, Inc.\DE is the larger business by last-quarter revenue ($70.6M vs $36.6M, roughly 1.9× TOP SHIPS INC.). TOP SHIPS INC. runs the higher net margin — -12.2% vs -49.0%, a 36.8% gap on every dollar of revenue.
Top Ships Inc. is a supply chain maritime transportation operations management company responsible for seaborne trade of raw materials. The company was founded by Evangelos J. Pistiolis on January 10, 2000 and is headquartered in Maroussi, Greece.
Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.
TOPS vs VRDN — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $36.6M | $70.6M |
| Net Profit | $-4.5M | $-34.6M |
| Gross Margin | — | — |
| Operating Margin | 22.0% | -56.7% |
| Net Margin | -12.2% | -49.0% |
| Revenue YoY | — | 81958.1% |
| Net Profit YoY | — | 54.9% |
| EPS (diluted) | $-0.96 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $20.4M | $490.9M |
| Total DebtLower is stronger | $216.6M | — |
| Stockholders' EquityBook value | $89.2M | $503.0M |
| Total Assets | $333.6M | $577.1M |
| Debt / EquityLower = less leverage | 2.43× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $20.4M | — | ||
| Q3 25 | — | $490.9M |
| Q4 25 | $216.6M | — | ||
| Q3 25 | — | — |
| Q4 25 | $89.2M | — | ||
| Q3 25 | — | $503.0M |
| Q4 25 | $333.6M | — | ||
| Q3 25 | — | $577.1M |
| Q4 25 | 2.43× | — | ||
| Q3 25 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.4M | $-84.6M |
| Free Cash FlowOCF − Capex | — | $-84.7M |
| FCF MarginFCF / Revenue | — | -120.1% |
| Capex IntensityCapex / Revenue | — | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.4M | — | ||
| Q3 25 | — | $-84.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | $-84.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | -120.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.2% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
